application:It is used to treat advanced renal cell carcinoma.
description:Erlotinib is an EGFR inhibitor. The drug follows Iressa (gefitinib), which was the first drug of this type. Erlotinib specifically targets the epidermal growth factor receptor (EGFR) tyrosine kinase, which is highly expressed and occasionally mutated in various forms of cancer. It binds in a reversible fashion to the adenosine triphosphate (ATP) binding site of the receptor.For the signal to be transmitted, two EGFR molecules need to come together to form a homodimer. These then use the molecule of ATP to trans-phosphorylate each other on tyrosine residues, which generates phosphotyrosine residues, recruiting the phosphotyrosine-binding proteins to EGFR to assemble protein complexes that transduce signal cascades to the nucleus or activate other cellular biochemical processes. By inhibiting the ATP, formation of phosphotyrosine residues in EGFR is not possible and the signal cascades are not initiated.
Please at any time if you are interested in Erlotinib.
If you want to know about Erlotinib price , please call our Customer Services Hotline +86 592 5365887 or send the email to firstname.lastname@example.org.
Tel: +86 592 5365887
WhatsApp: +86 189 6515 7632
Leave a Message
We will contact you within 24 hours.